// App-Quantinova.ai

359 : What makes a successful Phase 2 study: An evaluation of Parkinson’s neuroprotective trial design over the last 5 years

Researchers

Presenter

  • T. Dominey

Principal Investigators

  • S. Buff

  • G. Rafaloff

  • C. Carroll

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Parkinson's disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved